Maria Grazia Chiuri's Most Iconic Moments at Dior
When Maria Grazia Chiuri ascended to the helm of Christian Dior in 2016, she brought with her a reverence for tailoring, a romantic slant, a respect for the house's past, and her signature feminist fire. The first woman to lead the French fashion house since it was founded in 1946, she revolutionized the Dior woman with wearable yet interesting clothes made for an array of occasions and generations.
Throughout her time as creative director, Chiuri embraced the house codes with flair, softening the sculptural characteristics of Monsieur Dior's original 'New Look' throughout both ready-to-wear and couture collections. She fleshed out the tailoring aspects and embraced unique aspects of the house's DNA, like Dior's connection with ballet and devotion to tarot cards (Monsieur Dior designed costumes for the ballet and had a personal affinity for tarot cards). Not to mention, Chiuri's released accessories that ascended to cult-favorite status—remember the J'adior kitten heels?—and handbags like the Book tote, whose massive sales fueled the business side of the legacy brand.
Over the last decade, Chiuri also staged theatrical, imaginative runway shows in Paris and abroad. She's known for embracing the heritage of each place she travels, be it Morocco or Mexico City, to stage her larger-than-life resort and pre-fall shows, employing local artisans and feminist creatives to add to the Dior dialogue. In addition to immaculately constructed clothing, her Paris shows often featured the unique work of artists, choreographers, and performers.
On the red carpet, Dior ambassadors, from Jennifer Lawrence to Charlize Theron to Natalie Portman, bolstered the brand's iconography on a global platform.
Here, we've highlighted the most iconic moments throughout Chiuri's celebrated tenure to celebrate her legacy.Exercising her feminist side, Grazia Chiuri referenced Nigerian author Chimamanda Ngozi Adichie's 'We Should All Be Feminists' essay on t-shirts in her debut collection.First released with the spring 2017 collection, Chiuri's J'Adior kitten heels quickly ascended to cult-favorite status.Bella Hadid wore the standout look from Chiuri's debut collection at a Dior Beauty party in New York in 2016, spawning a new transparent trend.The Spring 2018 collection witnessed the launch of the iconic Dior Book Tote.Chiuri often enlisted model Ruth Bell, with her signature short hair, to open shows and front her campaigns.Dior re-released the house's iconic Saddle bag in 2018.The house of Dior has a history of intertwining with the ballet—Monsieur Dior designed costumes for performances in Paris. Chiuri expanded on that, as seen in the Spring 2019 collection.The Resort 2020 collection, shown in Morocco, utilized wax printing, a technique authentic to that part of North Africa.At the 2020 Oscars, Natalie Portman wore a cape embroidered with the names of female directors who failed to be nominated that year.For her Spring 2020 Haute Couture show, Chiuri reimagined the Greco-Roman goddess with billowing pleated skirts and twisted draping.The Spring 2021 couture show featured Renaissance-inspired silhouettes in the form of iconic Tarot figures.Yara Shahidi wore a spectacular Chiuri creation to the 2021 Met Gala.Chiuri continuously found new ways to riff on Dior's iconic bar jacket like this double-breasted number from Spring '22 couture.At the Cannes Film Festival in 2023, Dior Beauty ambassador Natalie Portman wore a Dior couture gown inspired by the iconic 'Junon' dress designed by Christian Dior in 1949.Chiuri showed her Pre-Fall 2023 collection in India.Chiuri closed the Dior Resort 2024, shown in Mexico City, with a parade of white dresses featuring red embroidery of artist and activist Elina Chauvet and a collective of female artisans.Jennifer Lawrence wore a charming Dior polka-dot number to the 2024 Oscars.Most recently, Chiuri re-released the iconic J'Adore Dior T-shirt in the Fall 2025 collection.Yseult wore a new rendition of the iconic 'New Look' at the Cannes Film Festival in 2024.Celine Dion wore Dior for her performance at the Opening Ceremony of the 2024 Olympics in Paris.
You Might Also Like
4 Investment-Worthy Skincare Finds From Sephora
The 17 Best Retinol Creams Worth Adding to Your Skin Care Routine
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Sanofi to acquire Blueprint for up to $9.5B
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Looking to further amp up its immunology business, Sanofi has agreed to acquire Blueprint Medicines in a deal that could be worth as much as $9.5 billion. Blueprint's research revolves around an enzyme made by a gene called KIT. This 'tyrosine kinase' enzyme helps control cell development, division and survival, so if it mutates, it can spur the type of uncontrolled cell growth seen in cancer and some rare diseases. Blueprint already has one medicine approved by the Food and Drug Administration, Ayvakit, and is working on a handful of others, two of which are in human testing. The FDA first approved Ayvakit in early 2020 for a rare kind of hard-to-treat gastrointestinal tumor, and specifically for the small subset of adults who have these tumors and certain mutations. Since then, the agency cleared the medicine as a treatment for both the less and more aggressive forms of 'systemic mastocytosis,' an uncommon disorder where a kind of white blood cell known as a mast cell builds up in the bone marrow, digestive tract, skin and other organs. The accumulation can lead to severe inflammation and organ damage. Last year, Blueprint posted $479 million in net product revenue from Ayvakit. The company used to have another marketed cancer drug, Gavreto, which it was co-developing and commercializing with Roche. But Roche ultimately backed away from that alliance, leading Blueprint to sell away rights to Rigel Pharmaceuticals in early 2024. In a statement announcing the deal, Sanofi highlighted the recent trajectory in Ayvakit sales. They were up more than 60%, for example, between the first quarter of 2024 and the same three-month period this year. Blueprint recorded a $67 million net loss in 2024, compared to a more than half-a-billion-dollar net loss in each of the previous two years. The proposed acquisition 'represents a strategic step forward in our rare and immunology portfolios,' Sanofi CEO Paul Hudson said in the Monday statement. 'It enhances our pipeline and accelerates our transformation into the world's leading immunology company.' Hudson added that his company maintains a 'sizeable capacity for further acquisitions.' After being an active dealmaker over the past few years, the French pharmaceutical giant still had close to 8 billion euros in cash and cash equivalents at the end of March. Sanofi bought the diabetes drug developer Provention Bio for almost $3 billion in 2023 and the rare disease-focused Inhibrix for $2.2 billion in 2024. And just last month, it agreed to spend $470 million on Vigil Neuroscience, a Massachusetts-based biotechnology company touting an Alzheimer's disease drug that just finished an early-stage human study. Similar to its Vigil proposal, Sanofi is offering Blueprint investors a so-called contingent value right that could be worth up to $6 per Blueprint share, provided one of the biotech's experimental drugs, 'BLU-808,' hits certain development and regulatory goals. BLU-808 is in mid-stage testing as a possible treatment for chronic hives and an allergy-related condition that causes runny eyes and a congested nose. Blueprint also believes the drug could be useful in treating allergic asthma and 'mast cell activation syndrome.' Another Blueprint drug, elenestinib, is further along, having advanced to a late-stage study for the slower-moving form of systemic mastocytosis. Sanofi's upfront payment of $9.1 billion values Blueprint shares at $129 apiece, reflecting a premium of about 27% from the biotech's closing stock price on Friday. The transaction is expected to close sometime between July and the end of September, according to Sanofi. Andrew Berens, an analyst at the investment firm Leerink Partners, wrote in a note to clients how his team expected Blueprint to land on the 'strategic radar of large pharma' given Ayvakit is on the path to $1 billion or more in annual sales and the company recently raised its financial guidance for this year. However, the deal came sooner than anticipated, ahead of a key data readout for a rival drug from Cogent Biosciences. Cogent's bezuclastinib is also being evaluated as a treatment for systemic mastocytosis, with results set to arrive in the next couple months. Regardless of how strong or weak those results will be, Berens believes they'd serve as a tailwind for Blueprint 'by removing a key overhang and allowing a strategic acquirer to structure a deal based on assumptions about ... market dynamics.' As such, Cogent's data could have propped up Blueprint's share price, 'which may have been an impetus for Sanofi to do the deal now,' Berens posited. Even so, the analyst still sees Sanofi's bid as a positive for Blueprint and this field of research. Cogent shares were down by about 2% late Monday morning. Recommended Reading Blueprint wins key FDA approval for rare disease drug Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
40 minutes ago
- Yahoo
France Charges 25 People, Including 6 Minors, in Crypto Kidnapping Cases
French authorities have charged 25 people, including six minors, for their roles in a spate of crypto kidnappings in Paris, with the majority of the suspects connected to the recent failed kidnapping attempt of a crypto exchange CEO's family, Paris's public prosecutor's office said, Le Monde reported Saturday. The investigation is focused on the kidnapping attempt of the daughter and grandson of the CEO of crypto exchange Paymium, Pierre Noizat, that occurred on May 13, the report said. The probe also looked at other unsuccessful kidnapping attempts, including an earlier attempt on Noizat's family members, plus an attempted abduction near the western city of Nantes last Monday that authorities thwarted. The arrests follow a spate of high-profile crypto kidnappings that have plagued France this year. In May the father of a French crypto millionaire was kidnapped, the BBC reported. At the start of the year David Ballard, a co-founder of crypto-wallet developer Ledger was kidnapped alongside his wife. Both of the men had a finger severed, with videos of the appendage used to extract a ransom. Following the recent kidnappings France's Minister of the Interior Bruno Retailleau hosted a meeting with crypto stakeholders in May to discuss measures to keep them secure. The suspects involved in the May 13 case were between the ages of 16 and 23 years; six of them were minors, the Le Monde report said. They were mostly born in France while three individuals were from Senegal, Angola and Russia, the report cited prosecutors as saying. This case is characterized by "very young profiles, lured by money and then caught up in a situation that is beyond them," observed lawyer Ambroise Vienet-Legué, who is defending an 18-year-old suspect in the Nantes part of the case, the report said. A source familiar with the investigation told CoinDesk that the suspects are believed to be locally-hired muscle, who are paid by a criminal operation in Southeast Asia to carry out the kidnappings for as little as $10,000. Eighteen people are in pre-trial detention, three have requested a deferred hearing while four are under judicial supervision, the public prosecutor said. Though France has been the epicenter of crypto kidnappings, similar crimes are on the rise across the globe, including recent several cases in the U.S. CoinDesk reached out to Paris's prosecution office for a comment.
Elle
43 minutes ago
- Elle
Go Inside NYC's Must-Visit New Dior Exhibit
From Christian Dior to Gianfranco Ferré and Maria Grazia Chiuri, Dior's legacy is one of the utmost beauty and refinement. Now, UBS House of Craft has partnered with the atelier to connect the designs of all seven creative directors in a single show unlike ever before. Curated by iconic fashion stylist and editor Carine Roitfeld and photographed by Brigitte Niedermair, the exhibit examines the intricate and historic craft of couture through a uniquely modern lens. The project offered Roitfeld personal access to the archives, where she explored eight decades of history and hand-selected iconic looks—ranging from an eclectic spring 2015 couture minidress by Raf Simons to a extraordinarily chic crocodile jacket from fall 1960 couture by Yves Saint Laurent. 'It was a lot of work, but a lot of fun. And because we know the house very well, both of us, we have a nexus to everything we want,' Roitfeld tells ELLE. The curated archive was then photographed by Niedermair, a longtime collaborator of the house (who has also shot for ELLE.) Through her lens, each piece transcends its original era and is brought into the editorial light of the present day. Adds Roitfeld, 'We learned so many things. And even though we are very respectful, we still had some freedom. It was very important for Brigitte and me to have some freedom for the picture.' Throughout the exhibit, a select few of the actual garments were juxtaposed in front of Niedermair's modern editorial images. Observing these rare archive items, like the crown from John Galliano's fall 2004 couture collection and the original 1947 Bar ensemble, up close felt like paying tribute to invaluable pieces of fashion history. 'Above all, this alliance is a celebration of excellence, haute couture elegance, and the exceptional savoir-faire deployed by Dior since the triumph of the New Look in 1947,' said Olivier Bialobos, UBS's deputy managing director in charge of global communication and image, in a statement. 'This artistic dialogue is a tribute to audacity and virtuoso artisanship, at the convergence of past, present, and future, in a perpetually shifting cultural landscape.' UBS House of Craft x Dior is open and free to the public from June 6-8 at 28 Pine Street in New York's Financial District.
